About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- Intoxication causes sedation, ataxia, slurred speech, impaired coordination, respiratory depression with opioids/alcohol
- Withdrawal can cause anxiety, insomnia, tremor, perceptual disturbance, seizures, psychosis, delirium
- Risk is higher with high dose, long duration, alprazolam, and alcohol use
- Treatment is gradual taper, often converting to longer-acting benzodiazepine
- Avoid routine flumazenil in chronic users or mixed overdose
Overview
Sedative, hypnotic, or anxiolytic use disorder requires problematic use and impairment. Physiologic dependence alone can occur with prescribed use. Withdrawal resembles alcohol withdrawal due to GABAergic adaptation and can be fatal.
Epidemiology
Long-term benzodiazepines are associated with tolerance, dependence, falls, cognitive impairment, crashes, and overdose, especially with opioids/alcohol and in older adults.
Clinical Features
Symptoms
Escalating use, craving, early refills, use despite harm
Intoxication: drowsiness, ataxia, slurred speech, falls, amnesia
Withdrawal: rebound anxiety, insomnia, tremor, sweating, perceptual changes
Seizures, delirium, psychosis after abrupt cessation
Respiratory depression/coma with opioids or alcohol
Signs
Sedation, impaired coordination, nystagmus, unsteady gait
Withdrawal tremor, tachycardia, hypertension, agitation
Confusion, hallucinations, seizures, fluctuating attention
Falls, fractures, bruising, co-ingestion signs
Investigations
First-line
Use/withdrawal historyAgent, dose, duration, last use, prescribed/nonmedical, prior seizures, alcohol/opioid co-use
Safety assessmentOverdose, respiratory depression, suicidality, falls, driving risk, cognition
Toxicology/PDMPScreens may miss some agents; review PDMP and sedative/opioid combinations
Second-line
Labs/ECGCMP, glucose, pregnancy, ECG if overdose/co-ingestion/electrolyte risk
Withdrawal scaleSupports monitoring; clinical judgment essential
Cognitive/falls assessmentEspecially older adults
Specialist
Emergency/ICUSeizures, delirium, severe withdrawal, respiratory depression, polysubstance overdose
Addiction psychiatryComplex taper, high-dose use, co-occurring SUD, failed taper
1
Overdose
- ABCs, airway/ventilation support, monitor co-ingestants
- Avoid flumazenil in chronic users, seizure disorder, or mixed overdose, especially TCA
- Consider flumazenil only for rare benzodiazepine-naive procedural oversedation under expert care
2
Withdrawal/taper
- Do not abruptly stop chronic benzodiazepines
- Taper gradually; consider longer-acting diazepam/clonazepam in selected patients
- Use slower taper for long-term/high-dose use, older adults, severe anxiety
3
Underlying condition/risk reduction
- Use CBT and SSRI/SNRI/buspirone for anxiety rather than chronic benzodiazepines
- Use CBT-I for insomnia
- Avoid opioid/benzodiazepine co-prescribing when possible
Complications
- Withdrawal seizures/delirium:
- Overdose with opioids/alcohol:
- Falls/fractures:
- Cognitive impairment:
- Motor vehicle crashes:
- Tolerance/dependence:
USMLE Step 2 CK Exam Tips
- 1Benzo withdrawal can cause seizures/delirium
- 2Flumazenil is a trap in chronic users/mixed overdose
- 3Best next step is gradual taper
- 4Alprazolam has high misuse/withdrawal risk
- 5Avoid benzodiazepines in older adults with falls
- 6Benzos + opioids increase fatal respiratory depression
practicetest your knowledge on benzodiazepine use disorder & withdrawalApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — psychiatry and beyond.
open q-bank